Original ResearchPublished 12 October 2026Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinomaOndřej Fiala · Jan Králíček · Jindřich Kopecký · Michal Vočka · Tomas Buchler · Hana Študentová · Jana Obertová · Beáta Rondzíková · Martin Matějů · Dominik Šafčák · Matej Hrnčár · Peter Priester · Martina Spisarová · Anežka Zemánková · Radka Lohynská · Michaela Tkadlecová · Lucie Grmelová · Petr Stránský · Bohuslav Melichar · Patrik Palacka · Alexandr PoprachFrontiers in Immunologydoi 10.3389/fimmu.2026.1944728
Case ReportPublished 9 October 2026Durable partial response with low-dose, intermittent nivolumab in combination with gemcitabine for high PD-L1 metastatic triple-negative breast cancer: a case reportPo Lin Ooi · Jamin Munchar Elias · Francis Yew Fu TiengFrontiers in Oncologydoi 10.3389/fonc.2026.1964934
ReviewPublished 7 October 2026Liver-resident cellular determinants of oncolytic virotherapy in hepatocellular carcinoma: viral susceptibility and spatial immune remodelingDing Hu · Qiong WangFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1959317
Letter to the EditorPublished 1 September 2026Resolution of direct antiglobulin test-negative autoimmune hemolytic anemia without corticosteroid therapy after discontinuation of nivolumab plus ipilimumab therapy for subungual melanomaMichiko Nakajima · Shintaro Saito · Mizuki Sato · Mizuho Nakajima · Sahori Yamazaki · Masahito Yasuda · Sei-ichiro MotegiJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2026.17320
Case ReportPublished 22 June 2026Durable disease control after multimodal therapy and platinum-based chemotherapy rechallenge in advanced clear cell adenocarcinoma of the urethra with lymph node metastases: a case reportAkihiro Maeda · Shohei Tobu · Shuhei Kusano · Maki Kawasaki · Hiroaki Kakinoki · Mitsuru NoguchiFrontiers in Urologydoi 10.3389/fruro.2026.1865730
Letter to the EditorPublished 29 May 2026Remarkable effect of nivolumab on late liver metastasis recurrence in advanced malignant melanomaShoka Fukuizumi · Soichiro Kado · Takayo Ando · Atsuko Sato · Koji Kamiya · Takeo Maekawa · Mamitaro Ohtsuki · Mayumi KomineJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2026.16775
Case ReportPublished 23 January 2026Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphomaGuilherme Gasparini Spiandorelo · Ahmed Alnughmush · Olivia Crum · Dragan Jevremovic · J. C. VillasboasFrontiers in Hematologydoi 10.3389/frhem.2025.1683981
Science archivePublished 10 July 2025Two cases of Stevens-Johnson syndrome presenting severe ocular complications associated with immune checkpoint inhibitorYukiko Nakahara-Omori · Yukari Kobayashi · Sumiko Ishizaki · Kyoko Chujo · Chikako Suto · Masaru Tanaka · Noriko Umegaki-AraoJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2025.14843
